Omega-3 fatty acids
- Generic Name
- Omega-3 fatty acids
- Brand Names
- Animi-3 With Vitamin D, Vitafol-one
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 329042-31-1
- Unique Ingredient Identifier
- 71M78END5S
- Background
Omega-3 fatty acids are polyunsaturated fatty acids (PUFAs) with a double bond at the third carbon atom from the end of the carbon chain. The three types of omega-3 fatty acids involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) (both commonly found in fish oil that origin...
- Indication
Provided as daily supplements. Aa preparation of omega-3-acid ethyl esters is licensed in UK for prevention of recurrent events after myocardial infarction in addition to treatment of hypertriglyceridaemia.
- Associated Conditions
- -
- Associated Therapies
- Nutritional supplementation, Parenteral Nutrition
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2013-06-05
- Last Posted Date
- 2019-10-30
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 57
- Registration Number
- NCT01869764
- Locations
- 🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States
Omega-3 and Quality of Life in Recurrent Aphthous Stomatitis Patients
- First Posted Date
- 2013-04-15
- Last Posted Date
- 2013-04-15
- Lead Sponsor
- October 6 University
- Target Recruit Count
- 50
- Registration Number
- NCT01831453
- Locations
- 🇪🇬
October 6 university, Cairo, Governarate of 6 of October, Egypt
Effect of Omega-3 Fatty Acid on Endothelial Function
- First Posted Date
- 2013-03-18
- Last Posted Date
- 2019-05-13
- Lead Sponsor
- Nordlandssykehuset HF
- Target Recruit Count
- 34
- Registration Number
- NCT01813006
- Locations
- 🇳🇴
Division of Internal Medicine, Nordland Hospital, Bodø, Norway
DO-HEALTH / Vitamin D3 - Omega3 - Home Exercise - Healthy Ageing and Longevity Trial
- First Posted Date
- 2012-12-10
- Last Posted Date
- 2018-08-09
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 2157
- Registration Number
- NCT01745263
- Locations
- 🇫🇷
University of Toulouse - Centre de Recherche - Gérontopôle Hôpital La Grave, Toulouse, France
🇩🇪Charité Berlin, Berlin, Germany
🇵🇹University of Coimbra - Clínica Universitária de Reumatologia, Coimbra, Portugal
The Effects of Omega-3 Fatty Acids in Renal Transplantation
- Conditions
- Interventions
- First Posted Date
- 2012-12-06
- Last Posted Date
- 2015-12-08
- Lead Sponsor
- Oslo University Hospital
- Target Recruit Count
- 132
- Registration Number
- NCT01744067
- Locations
- 🇳🇴
Oslo University Hospital Rikshospitalet, Oslo, * Other, Norway
🇳🇴Oslo University Hospital, Rikshospitalet, Oslo, Norway
Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids
- Conditions
- Interventions
- First Posted Date
- 2012-11-26
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 60
- Registration Number
- NCT01733147
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder
- Conditions
- Interventions
- First Posted Date
- 2012-09-27
- Last Posted Date
- 2020-08-31
- Target Recruit Count
- 57
- Registration Number
- NCT01694667
- Locations
- 🇺🇸
This study is open to continental USA, Multiple Locations, Maryland, United States
Omega-3 Fatty Acids and Insulin Sensitivity
- First Posted Date
- 2012-09-18
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 31
- Registration Number
- NCT01686568
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Citicoline and Omega-3 Fatty Acid Effects in Veterans With Traumatic Brain Injury (TBI)
- Conditions
- Interventions
- First Posted Date
- 2012-01-24
- Last Posted Date
- 2015-01-19
- Lead Sponsor
- Deborah Yurgelun-Todd
- Registration Number
- NCT01515917
Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits
- Conditions
- Interventions
- First Posted Date
- 2011-07-22
- Last Posted Date
- 2018-10-23
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 2
- Registration Number
- NCT01399827
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.